Apr 25 to Apr 26 2013
Toronto, ON, Canada
Date to register by: Apr 25 2013
Target Audience: Practicing pathologists, pathology residents, and technologists
http://ciqc-capconference.eventbrite.com/
Credits:
This event is an Accredited Group Learning Activity, Section 1, as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and co-developed by the Canadian Association of Pathologists and Cancer Care Ontario.
This activity was approved by the Canadian Association of Pathologists for 15 Section 1 credits. Remember to visit MAINPORT to record your learning and outcomes.
Venue: Metropolitan Hotel, 108 Chestnut Street, Toronto, Ontario
Click here for detailed Program and Information.
Thursday, April 25, 2013
8:00-8:05 Welcome and Introductory Remarks: B Gilks and E Torlakovic
8:05-8:30 CIQC update: E Torlakovic and J Garratt
8:30-9:15 The NordiQC program: an overview: M Vyberg
9:15-10:00 IHC Proficiency Testing in Germany: R von Wasielewski
10:00-10:30 Break
10:30-11:00 Technical approach to IHC testing: the NordiQC perspective: S Nielsen
11:00-11:30 MMR testing in Canada: CIQC results: B Clarke
11:30-12:00 Reflex MMR testing in Vancouver, one year in: R Wolber
12:00 – 1:00 LUNCH
1:00-1:45 Classification of the unknown primary tumour: the primary IHC panel: M Vyberg
1:45-2:05 Antibodies and protocols: the primary IHC panel: S Nielsen
2:05-2:30 Use of tissue samples for IHC quality control and research: C Cheung
2:30-3:00 Update on Ki67 assessment in breast cancer; an international study: T Nielsen
3:00-3:20 Update on Class II tests in renal pathology: M Mengel
3:20-3:40 Break
3:40-4:10 New markers in hematopathology: E Hyjek
4:10-5:00 Immunophenotyping of neuroendocrine tumors: current status and recent
developments: S Asa
5:00 Adjourn
Friday, April 26, 2013
8:00-9:00 IHC as a Window onto the Molecular Biology of Tumors: A Gown
9:00-9:30 IHC and molecular testing in diagnosis of ovarian sex-cord stromal tumors: B Gilks
9:30-10:00 Break
10:00-10:55 Critical Technical Aspects of Diagnostic Immunohistochemistry: R Miller
10:55-11:40 Cytokeratins and other general epithelial markers in diagnostic IHC: M Vyberg
11:40-12:00 Antibodies and protocols - epithelial markers: S Nielsen
12:00 – 1:00 LUNCH
1:00-5:00 Specialty Course: Molecular Pathology
Review of Molecular Pathology in Caner Diagnosis and Therapy
M Tsao (moderator)
1:00-1:10 Introductory Remarks: D LeBrun
1:10 – 1:50 Lung: M Tsao
1:50 – 2:20 Prostate: D Trudel
2:20 – 3:00 Lymphomas: D LeBrun
3:00 – 3:15 Break
3:15 – 4:00 Breast: S Done
4:00 – 4:45 Theranostic and morphoproteomics: E Torlakovic
4:45 – 5:00 Closing remarks: M Tsao